Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New device offers hope for chronic constipation sufferers

NCT ID NCT04666155

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a new device called MOWOOT for people with chronic constipation. 86 adults who already used standard treatment (trans-anal irrigation) tried the MOWOOT device to see if it improved their symptoms and quality of life. The goal was to compare the new device's effectiveness and cost against standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

86 people

The number who actually took part.

Started

Apr 2024

Finished

Mar 2026

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 99 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Any gender 18 years or older 2. Symptoms meeting the American College of Gastroenterology definition of chronic constipation: unsatisfactory defaecation characterized by infrequent stool, difficult stool passage or both for at least previous 3 months 3. Bothered by their constipation 4. PAC-QOL ≥1.8 5. Using TAI for at least 3 months 6. Able to undertake the treatment with TAI or with the device themselves or with a carer willing to do it 7. Able to understand the study requirements 8. Able to understand written and spoken English (due to questionnaire validity) 9. Able and willing to provide written informed consent to participate Exclusion Criteria: Disease phenotype exclusion criteria: 1. Irritable Bowel Syndrome with Diarrhoea (IBS-D) or alternating constipation and diarrhoea (IBSmix): (not due to laxative use) 2. Inflammatory Bowel Disease (IBD) Device-related exclusion criteria: 3. Abdominal perimeter ≤65cm or ≥130cm 4. Unable to independently use the MOWOOT or TAI technology, unless a carer is available daily to assist Other medical conditions, medications and contraindications: 5. Previous large bowel resection 6. The presence of a stoma 7. External rectal prolapse 8. Active anorexia or bulimia 9. Active abdominal cancer 10. Large inguinal or umbilical hernia 11. Recent abdominal scars, abdominal wounds or skin disorders that may make abdominal massage uncomfortable 12. Pregnancy or attempt to become pregnant in the next 6 months 13. Use of strong opioids\* 14. Use of antidepressants, bladder stabilisers or any other medication inducing, or treating, constipation unless used at a stable dose for at least 4 weeks before Screening Visit (this excludes laxatives which may be used as required up to three days before the screening visit) 15. Subjects already undertaking or have undertaken abdominal massage unless they underwent a previous washout period of at least 2 months 16. Participation in another parallel interventional clinical trial or less than 2 months from participation in a previous interventional clinical trial 17. Planned surgery for constipation if it might be within trial dates

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Constipation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The Newcastle Upon Tune Hospitals NHS Foundation Trust.

    Newcastle upon Tyne, United Kingdom

  • University Hospital of North Durham, NHS Foundation Trust

    Durham, County Durham and Darlington, DH5TW, United Kingdom

  • University Hospital of North Tees, North Tees & Hartlepool NHS Foundation Trust

    Hardwick, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.